Tolerys SA - Company Review
Tolerys SA - Company ReviewSummary
Tolerys SA (Tolerys) is a biopharmaceutical company that develops immunotherapy products for chronic inflammatory diseases. The company's product portfolio includes EFD BCG, that is derived from bacillus calmette-guerin vaccine by utilizing a patented inactivation process, based on the immunological properties of mycobacteria. The company generates efficacy data about pre-clinical models of allergic asthma, inflammatory bowel diseases and data on atherosclerosis and primary cells. Tolerys utilizes EFD BCG to exploit the ability of mycobacteria induce a response anti-inflammatory via regulatory T cells. It also provides bio manufacturing services and expertise's in lyophilization. Tolerys is headquartered in Morges, Switzerland.
This comprehensive company report of Tolerys SA provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.